Safety Data Sheet

Taski R3
Revision: 2021-12-07 Version: 01.0

SECTION 1: Identification of the substance/mixture and of the company/undertaking

1.1 Product identifier
Trade name: Taski R3

1.2 Recommended use and restrictions on use

See product label.
For professional use only.

1.3 Details of the supplier of the safety data sheet

Diversey Gulf FZE

Contact details
Street N302, Plot No. 0528, Jebel Ali Free Zone, Dubai, UAE
Tel. +971 4881 9470 Fax +971 4 8819488

1.4 Emergency telephone number

+971 4881 9470

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Not classified as hazardous

2.2 Label elements

2.3 Other hazards
No other hazards known.

2.4 Classification diluted product:

Recommended maximum concentration (% w/w): 10

Not classified as hazardous

SECTION 3: Composition/information on ingredients

3.1 Substances / Mixtures
The product contains no substances classified as hazardous in concentrations which should be taken into account.

Ingredient(s) CAS number EC number Classification Weight percent

- - - Not classified as hazardous -

Ingredient(s)
anionic surfactants, non-ionic surfactants <5%
perfumes , Hexyl Cinnamal, Butylphenyl Methylpropional, Phenoxyethanol, Benzisothiazolinone

SECTION 4: First aid measures

4.1 Description of first aid measures
Inhalation: Get medical attention or advice if you feel unwell.
Skin contact: Wash skin with plenty of lukewarm, gently flowing water. If skin irritation occurs: Get medical advice
or attention.
Eye contact: Rinse cautiously with water for several minutes. If irritation occurs and persists, get medical
attention.
Ingestion: Rinse mouth. Immediately drink 1 glass of water. Never give anything by mouth to an unconscious
person. Get medical attention or advice if you feel unwell.
Self-protection of first aider: Consider personal protective equipment as indicated in subsection 8.2.

Page 1 / 8
 Safety Data Sheet
Taski R3

4.2 Most important symptoms and effects, both acute and delayed
Inhalation: No known effects or symptoms in normal use.
Skin contact: No known effects or symptoms in normal use.
Eye contact: No known effects or symptoms in normal use.
Ingestion: No known effects or symptoms in normal use.

4.3 Indication of any immediate medical attention and special treatment needed
No information available on clinical testing and medical monitoring. Specific toxicological information on substances, if available, can be found
in section 11.

SECTION 5: Firefighting measures

5.1 Extinguishing media
Carbon dioxide. Dry powder. Water spray jet. Fight larger fires with water spray jet or alcohol-resistant foam.

5.2 Special hazards arising from the substance or mixture

No special hazards known.

5.3 Advice for firefighters

As in any fire, wear self contained breathing apparatus and suitable protective clothing including gloves and eye/face protection.

SECTION 6: Accidental release measures

6.1 Personal precautions, protective equipment and emergency procedures
No special measures required.

6.2 Environmental precautions

Dilute with plenty of water. Do not allow to enter drainage system, surface or ground water.

6.3 Methods and material for containment and cleaning up

Dyke to collect large liquid spills. Absorb with liquid-binding material (sand, diatomite, universal binders, sawdust). Do not place spilled
materials back into the original container. Collect in closed and suitable containers for disposal.

6.4 Reference to other sections

For personal protective equipment see subsection 8.2. For disposal considerations see section 13.

SECTION 7: Handling and storage

7.1 Precautions for safe handling
Measures to prevent fire and explosions:
No special precautions required.

Measures required to protect the environment:

For environmental exposure controls see subsection 8.2.

Advices on general occupational hygiene:

Handle in accordance with good industrial hygiene and safety practice. Do not mix with other products unless adviced by Diversey. Do not
breathe spray.

7.2 Conditions for safe storage, including any incompatibilities

Store in accordance with local and national regulations. Keep only in original packaging.
For conditions to avoid see subsection 10.4. For incompatible materials see subsection 10.5.

7.3 Specific end use(s)

No specific advice for end use available.

SECTION 8: Exposure controls/personal protection

8.1 Control parameters
Workplace exposure limits

Air limit values, if available:

Biological limit values, if available:

8.2 Exposure controls

The following information applies for the uses indicated in subsection 1.2 of the Safety Data Sheet.
If available, please refer to the product information sheet for application and handling instructions.
Normal use conditions are assumed for this section.

Page 2 / 8
 Safety Data Sheet
Taski R3

Recommended safety measures for handling the undiluted product:

Covering activities such as filling and transfer of product to application equipment, flasks or buckets

Appropriate engineering controls: No special requirements under normal use conditions.

Appropriate organisational controls: No special requirements under normal use conditions.

Personal protective equipment

Eye / face protection: Safety glasses are not normally required. However, their use is recommended in those cases where
splashes may occur when handling the product (EN 166).
Hand protection: No special requirements under normal use conditions.
Body protection: No special requirements under normal use conditions.
Respiratory protection: No special requirements under normal use conditions.

Environmental exposure controls: No special requirements under normal use conditions.

Recommended safety measures for handling the diluted product:

Recommended maximum concentration (% w/w): 10

Appropriate engineering controls: Use only in well ventilated areas.

Appropriate organisational controls: No special requirements under normal use conditions.

Personal protective equipment

Eye / face protection: No special requirements under normal use conditions.
Hand protection: No special requirements under normal use conditions.
Body protection: No special requirements under normal use conditions
Respiratory protection: Trigger spray bottle application: No special requirements under normal use conditions. Apply
technical measures to comply with the occupational exposure limits, if available

Environmental exposure controls: No special requirements under normal use conditions.

SECTION 9: Physical and chemical properties

9.1 Information on basic physical and chemical properties

Method / remark
Physical state: Liquid
Colour: Clear , Blue
Odour: Product specific
Odour threshold: Not applicable
pH: ≈ 8 (neat) ISO 4316
Dilution pH: ≈ 8 (10 %) ISO 4316
Melting point/freezing point (°C): Not determined Not relevant to classification of this product
Initial boiling point and boiling range (°C): Not determined

Flammability (liquid): Not flammable.

Flash point (°C): ≈ 57 °C closed cup
Sustained combustion: Not applicable.
( UN Manual of Tests and Criteria, section 32, L.2 )

Evaporation rate: Not determined Not relevant to classification of this product

Flammability (solid, gas): Not applicable to liquids
Lower and upper explosion limit/flammability limit (%): Not determined
Vapour pressure: Not determined
Relative vapour density - Not relevant to classification of this product
Relative density: ≈ 1.00 (20 °C) OECD 109 (EU A.3)
Solubility in / Miscibility with Water: Fully miscible
Partition coefficient: n-octanol/water No information available.

Substance data, partition coefficient n-octanol/water (log Kow): see subsection 12.3

Autoignition temperature: Not determined

Decomposition temperature: Not applicable.
Viscosity: Not determined
Explosive properties: Not explosive.
Oxidising properties: Not oxidising.

9.2 Other information

Page 3 / 8
 Safety Data Sheet
Taski R3

Surface tension (N/m): Not determined

Corrosion to metals: Not corrosive Weight of evidence
Contains 0.3 % volatile organic compounds.

SECTION 10: Stability and reactivity

10.1 Reactivity
No reactivity hazards known under normal storage and use conditions.

10.2 Chemical stability

Stable under normal storage and use conditions.

10.3 Possibility of hazardous reactions

No hazardous reactions known under normal storage and use conditions.

10.4 Conditions to avoid

None known under normal storage and use conditions.

10.5 Incompatible materials

None known under normal use conditions.

10.6 Hazardous decomposition products

None known under normal storage and use conditions.

SECTION 11: Toxicological information

11.1 Information on toxicological effects

Mixture data:.

Relevant calculated ATE(s):

ATE - Oral (mg/kg): >2000

Substance data, where relevant and available, are listed below:.

Acute toxicity
Acute oral toxicity
Ingredient(s) Endpoint Value Species Method Exposure
(mg/kg) time (h)
- No data
available

Acute dermal toxicity

Ingredient(s) Endpoint Value Species Method Exposure
(mg/kg) time (h)
- No data
available

Acute inhalative toxicity

Ingredient(s) Endpoint Value Species Method Exposure
(mg/l) time (h)
- No data
available

Irritation and corrosivity

Skin irritation and corrosivity
Ingredient(s) Result Species Method Exposure time
- No data available

Eye irritation and corrosivity

Ingredient(s) Result Species Method Exposure time
- No data available

Respiratory tract irritation and corrosivity

Ingredient(s) Result Species Method Exposure time
- No data available

Page 4 / 8
 Safety Data Sheet
Taski R3

Sensitisation
Sensitisation by skin contact
Ingredient(s) Result Species Method Exposure time (h)
- No data available

Sensitisation by inhalation
Ingredient(s) Result Species Method Exposure time
- No data available

CMR effects (carcinogenicity, mutagenicity and toxicity for reproduction)

Mutagenicity
Ingredient(s) Result (in-vitro) Method Result (in-vivo) Method
(in-vitro) (in-vivo)
- No data available No data available

Carcinogenicity
Ingredient(s) Effect
- No data available

Toxicity for reproduction

Ingredient(s) Endpoint Specific effect Value Species Method Exposure Remarks and other effects
(mg/kg bw/d) time reported
- No data
available

Repeated dose toxicity

Sub-acute or sub-chronic oral toxicity
Ingredient(s) Endpoint Value Species Method Exposure Specific effects and organs
(mg/kg bw/d) time (days) affected
- No data
available

Sub-chronic dermal toxicity

Ingredient(s) Endpoint Value Species Method Exposure Specific effects and organs
(mg/kg bw/d) time (days) affected
- No data
available

Sub-chronic inhalation toxicity

Ingredient(s) Endpoint Value Species Method Exposure Specific effects and organs
(mg/kg bw/d) time (days) affected
- No data
available

Chronic toxicity
Ingredient(s) Exposure Endpoint Value Species Method Exposure Specific effects and Remark
route (mg/kg bw/d) time organs affected
- No data
available

STOT-single exposure
Ingredient(s) Affected organ(s)
- No data available

STOT-repeated exposure
Ingredient(s) Affected organ(s)
- No data available

Aspiration hazard
Substances with an aspiration hazard (H304), if any, are listed in section 3.

Potential adverse health effects and symptoms

Effects and symptoms related to the product, if any, are listed in subsection 4.2.

SECTION 12: Ecological information

12.1 Toxicity

Page 5 / 8
 Safety Data Sheet
Taski R3

No data is available on the mixture.

Substance data, where relevant and available, are listed below:

Aquatic short-term toxicity

Aquatic short-term toxicity - fish
Ingredient(s) Endpoint Value Species Method Exposure
(mg/l) time (h)
- No data
available

Aquatic short-term toxicity - crustacea

Ingredient(s) Endpoint Value Species Method Exposure
(mg/l) time (h)
- No data
available

Aquatic short-term toxicity - algae

Ingredient(s) Endpoint Value Species Method Exposure
(mg/l) time (h)
- No data
available

Aquatic short-term toxicity - marine species

Ingredient(s) Endpoint Value Species Method Exposure
(mg/l) time (days)
- No data
available

Impact on sewage plants - toxicity to bacteria

Ingredient(s) Endpoint Value Inoculum Method Exposure
(mg/l) time
- No data
available

Aquatic long-term toxicity

Aquatic long-term toxicity - fish
Ingredient(s) Endpoint Value Species Method Exposure Effects observed
(mg/l) time
- No data
available

Aquatic long-term toxicity - crustacea

Ingredient(s) Endpoint Value Species Method Exposure Effects observed
(mg/l) time
- No data
available

Aquatic toxicity to other aquatic benthic organisms, including sediment-dwelling organisms, if available:

Terrestrial toxicity
Terrestrial toxicity - soil invertebrates, including earthworms, if available:

Terrestrial toxicity - plants, if available:

Terrestrial toxicity - birds, if available:

Terrestrial toxicity - beneficial insects, if available:

Terrestrial toxicity - soil bacteria, if available:

12.2 Persistence and degradability

Abiotic degradation
Abiotic degradation - photodegradation in air, if available:

Abiotic degradation - hydrolysis, if available:

Abiotic degradation - other processes, if available:

Page 6 / 8
 Safety Data Sheet
Taski R3

Biodegradation
Ready biodegradability - aerobic conditions
Ingredient(s) Inoculum Analytical DT 50 Method Evaluation
method
- No data available

Ready biodegradability - anaerobic and marine conditions, if available:

Degradation in relevant environmental compartments, if available:

12.3 Bioaccumulative potential

Partition coefficient n-octanol/water (log Kow)
Ingredient(s) Value Method Evaluation Remark
- No data available

Bioconcentration factor (BCF)

Ingredient(s) Value Species Method Evaluation Remark
- No data available

12.4 Mobility in soil

Adsorption/Desorption to soil or sediment
Ingredient(s) Adsorption Desorption Method Soil/sediment Evaluation
coefficient coefficient type
Log Koc Log Koc(des)
- No data available

12.5 Other adverse effects

No other adverse effects known.

SECTION 13: Disposal considerations

13.1 Waste treatment methods
Waste from residues / unused The concentrated contents or contaminated packaging should be disposed of by a certified handler
products: or according to the site permit. Release of waste to sewers is discouraged. The cleaned packaging
material is suitable for energy recovery or recycling in line with local legislation.

Empty packaging
Recommendation: Dispose of observing national or local regulations.
Suitable cleaning agents: Water, if necessary with cleaning agent.

SECTION 14: Transport information

Land transport, Sea transport (IMDG), Air transport (ICAO-TI / IATA-DGR)

14.1 UN number: Non-dangerous goods
14.2 UN proper shipping name: Non-dangerous goods
14.3 Transport hazard class(es): Non-dangerous goods
14.4 Packing group: Non-dangerous goods
14.5 Environmental hazards: Non-dangerous goods
14.6 Special precautions for user: Non-dangerous goods
14.7 Transport in bulk according to Annex II of MARPOL and the IBC Code: Non-dangerous goods

SECTION 15: Regulatory information

15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture

SECTION 16: Other information

The information in this document is based on our best present knowledge. However, it does not constitute a guarantee for any specific product
features and does not establish a legally binding contract

Page 7 / 8
 Safety Data Sheet
Taski R3

SDS code: MS1200984 Version: 01.0 Revision: 2021-12-07

Abbreviations and Acronyms

• ATE - Acute Toxicity Estimate
• DNEL - Derived No Effect Limit
• EC No. - European Community Number
• EC50 - effective concentration, 50%
• LC50 - Lethal Concentration, 50% / Median Lethal Concentration
• LD50 - Lethal Dose, 50% / Median Lethal dose
• NOAEL - No observed adverse effect level
• NOEL - No observed effect level
• OECD - Organization for Economic Cooperation and Development
• PNEC - Predicted No Effect Concentration
• STOT-RE - Specific target organ toxicity (repeated exposure)
• STOT-SE - Specific target organ toxicity (single exposure)

End of Safety Data Sheet

Page 8 / 8